Pulmonary Institute Rabin Medical center, Beilinson Hospital
Petah Tikva, 49100, Israel
NCT Number: NCT02805114
This is an observational study which aims to evaluate the possibility of using data from a capnography device to assess obstructive airway severity in both Chronic Obstructive Pulmonary Disease (COPD) and Asthma patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Petah Tikva, 49100, Israel
This is an observational study which aims to evaluate the possibility of using data from a capnography device to assess obstructive airway severity in both COPD and Asthma patients. The study will include adult asthma and COPD patients (age >18). Patients will be enrolled on a continuous basis and will be monitored by capnograph and oximeter before and after lung function assessment and also during and after medical treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1/2 hour to 48 hours from enrollment of subjects
Correlation between the airway obstruction severity calculation based on the capnography parameters and the clinical severity of asthma and COPD as defined by forced expiratory volume in 1 second (FEV1), in severe asthma and COPD patients
Oridion
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07598292
Asthma, Bronchial Diseases
Çorum, Turkey (Türkiye)
View Trial DetailsNCT04684836
Asthma, Bronchial Diseases
Gainesville, New York, United States
View Trial DetailsNCT05830071
Asthma, Bronchial Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT02742597
Alzheimer Disease, Alzheimer's Disease
London, Ontario, Canada
View Trial Details